# US 2022/0031950 A1 · Diabetes management system with automatic basal and manual bolus insulin control

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0031950 A1
- Document ID: US20220031950A1
- Status: Published application
- Kind: A1
- Application number: 17/503,720
- Filed: 2021-10-18
- Published: 2022-02-03
- Earliest claimed: 2017-04-18
- Assignees: LifeScan IP Holdings, LLC
- Applicants: Lifescan IP Holdings, LLC
- Inventors: Daniel Finan; Thomas McCann
- Web page: https://patentgrep.com/patent/US20220031950A1

## CPC

- A61M 5/1723: {using feedback of body parameters, e.g. blood sugar or pressure}
- A61M 5/142: Pressure infusion, e.g. using pumps
- A61M 5/14244: {adapted to be carried by the patient, e.g. portable on the body}
- A61M 5/178: Syringes
- G16H 20/17: delivered via infusion or injection
- A61M 2005/1726: {the body parameters being measured at, or proximate to, the infusion site}
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/505: Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

Systems and methods for diabetes management with automatic basal and manual bolus insulin control are presented. An exemplary system includes a delivery device, a glucose sensor, and a controller. The delivery device delivers insulin and the glucose sensor measures glucose levels of the subject. A basal insulin dose is calculated using a model predictive control algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels. A manual bolus insulin dose is initiated by the subject. The manual bolus insulin dose is modified based on one or both of the model predictive control algorithm and the physiological data of the subject. A total insulin dose is determined based on the modified manual bolus insulin dose and the calculated basal insulin dose, and delivered to the subject.

## Claims

### Claim 1

A diabetes management system comprising:
a delivery device for delivering insulin to a subject;
a glucose sensor for measuring glucose levels of the subject;
a bolus calculator into which a manual bolus insulin dose is initiated by the subject, the manual bolus insulin dose being determined by the bolus calculator as a function of a difference between a present glucose level of the subject, a glucose sensitivity of the subject, and an on-board insulin level of the subject; and
a controller configured to:
receive glucose levels of the subject from the glucose sensor on a periodic basis,
automatically calculate a basal insulin dose using a model predictive control (MPC) algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin, and the measured glucose levels of the subject,
receive the manual bolus insulin dose determined by the bolus calculator,
modify the manual bolus insulin dose based on the physiological data,
determine a total insulin dose based on the modified manual bolus insulin dose and the calculated basal insulin dose, and
deliver the total insulin dose to the subject.

### Claim 2 (depends on 1)

The diabetes management system of claim 1, wherein the physiological data of the subject comprises a rate of glucose change of the subject and the modifying comprises reducing the manual bolus insulin dose to account for the rate of glucose change.

### Claim 3 (depends on 1)

The diabetes management system of claim 1, wherein the controller is further configured to detect hypoglycemic excursions of the subject and cancel the manual bolus insulin dose responsive to the detected hypoglycemic excursions.

### Claim 4 (depends on 1)

The diabetes management system of claim 1, wherein the modifying comprises overriding the manual bolus insulin dose determined by the bolus calculator.

### Claim 5 (depends on 1)

The diabetes management system of claim 1, wherein the bolus calculator calculates the manual bolus insulin dose to achieve a target glucose level.

### Claim 6

A diabetes management system with automatic basal and manual bolus insulin control, the diabetes management system comprising:
a delivery device for delivering insulin to a subject;
a glucose sensor for measuring glucose levels of the subject;
a bolus calculator into which a manual bolus insulin dose is initiated by the subject, the manual bolus insulin dose being determined by the bolus calculator as a function of a difference between a present glucose level of the subject, a glucose sensitivity of the subject, and an on-board insulin level of the subject; and
a controller configured to:
receive glucose levels of the subject from the glucose sensor on a periodic basis,
automatically calculate a basal insulin dose using a model predictive control (MPC) algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels of the subject,
receive the manual bolus insulin dose determined by the bolus calculator,
modify the manual bolus insulin dose based on the MPC algorithm and physiological data of the subject.

### Claim 7 (depends on 6)

The diabetes management system of claim 6, wherein the controller is further configured to determine a total insulin dose based on the modified manual bolus insulin dose and the calculated basal insulin dose.

### Claim 8 (depends on 6)

The diabetes management system of claim 6, wherein the controller is further configured to command the delivery device to deliver the total insulin dose to the subject.

### Claim 9 (depends on 6)

The diabetes management system of claim 6, wherein the physiological data of the subject comprises a rate of glucose change of the subject and the modifying comprises reducing the manual bolus insulin dose to account for the rate of glucose change.

### Claim 10 (depends on 6)

The diabetes management system of claim 6, wherein the controller is further configured to detect hypoglycemic excursions of the subject and cancel the manual bolus insulin dose determined by the bolus calculator responsive to the detected hypoglycemic excursions.

### Claim 11 (depends on 6)

The diabetes management system of claim 6, wherein the modifying comprises overriding the manual bolus insulin dose determined by the bolus calculator.

### Claim 12

A method for managing diabetes using automatic basal and manual bolus insulin control in an artificial pancreas system having:
a delivery device for delivering insulin to a subject, a glucose sensor for measuring glucose levels of the subject, a bolus calculator configured to determine a manual bolus insulin dose, and a controller, the method comprising the steps of:
using the controller, receiving glucose levels of the subject from the glucose sensor on a periodic basis;
using the controller, automatically calculating a basal insulin dose using a model predictive control (MPC) algorithm and physiological data of the subject including desired glucose levels, amounts of the delivered insulin and the measured glucose levels of the subject;
using the bolus calculator, determining a manual bolus insulin dose based on physiological data of the subject as a function of a difference between a present glucose level and the target glucose level, a glucose sensitivity of the subject, and the on-board level of insulin of the subject;
having the controller receive the determined manual bolus insulin dose from the bolus calculator; and
modifying the determined manual bolus insulin dose determined by the bolus calculator based on the MPC algorithm and physiological data of the subject;
determining a total insulin dose based on the modified manual bolus insulin dose and the calculated basal insulin dose; and
commanding the delivery device to deliver the total insulin dose to the subject.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
using the MPC algorithm, determining whether there will be a near-future glycemic excursion of the subject based on the physiological data including rate of change of glucose, the near-future glycemic excursion being indicative of hypoglycemia; and
if a determination is made that there will be a near-future glycemic excursion indicative of hypoglycemia, then modifying the manual bolus insulin dose of the bolus calculator based on the predicted near-future glycemic excursion.

### Claim 14 (depends on 12)

The method of claim 12, wherein the modifying the manual bolus insulin dose comprises reducing or canceling the manual bolus insulin dose determined by the bolus calculator.

### Claim 15 (depends on 12)

The method of claim 12, wherein modifying the manual bolus insulin dose comprises calculating a function of a difference between a present glucose level of the subject and a target glucose level of the subject, a glucose sensitivity of the subject, and an on-board insulin level of the subject.

### Claim 16 (depends on 12)

The method of claim 12, wherein automatically calculating the basal insulin dose comprises using the MPC algorithm further based on a rate of glucose change of the subject, and the modifying comprises reducing the manual bolus insulin dose to account for the rate of glucose change.

### Claim 17 (depends on 12)

The method of claim 12, further comprising:
detecting at least one hypoglycemic excursion of the subject using the MPC algorithm; and
canceling the manual bolus insulin dose responsive to the detected at least one hypoglycemic excursion.

### Claim 18 (depends on 12)

The method of claim 12, further comprising, calculating the manual bolus insulin dose to achieve a target glucose level using the bolus calculator.
